Dhruv Bhutani has been writing about consumer technology since 2008, offering deep insights into the Android smartphone landscape through features and opinion pieces. He joined Android Police in 2023, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Have you ever opened your Apple Notes app, only to feel overwhelmed by a chaotic sea of random thoughts, to-do lists, and half-finished ideas? If so, you’re not alone. Many users rely on outdated ...

Eight AI bots contribute about 10 percent of the platform’s “Community Notes.” “We’ve definitely seen Community Notes in the past that have been inaccurate,” said Sofia Rubinson, a senior editor at ...

"The View" co-host Whoopi Goldberg tore up a note co-host Sunny Hostin passed to her on Monday that asked her to clarify a statement she made earlier in the show, which she said was a joke, about ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

VICTOR, N.Y.--(BUSINESS WIRE)--Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL,” the “Company,” “we,” “our,” or “us”), today announced that ...

Google Keep has been my go-to note-taking app for years, but I recently noticed that my disorganized notes were becoming overwhelming, making it harder to find what I was looking for. I had previously ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...

Anu is a Features author at Android Police. You'll find her writing in-depth pieces about automation tools, productivity apps, and explainers. Before joining AP, she used to write for prominent tech ...